Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Frist Cressey Ventures (FCV) is a venture capital firm established in 2016 by Senator Bill Frist, M.D., and Bryan Cressey. The firm is headquartered in Nashville, Tennessee, with an additional office in New York. FCV is dedicated to transforming healthcare and enhancing patient outcomes through strategic investments and partnerships. The firm has a strong commitment to addressing health inequities and improving access to care, focusing on companies that leverage technology to streamline healthcare delivery.
As of now, FCV manages assets totaling approximately $756 million across its funds, with its latest fund, Fund IV, closing at $425 million in February 2026. The firm has built a notable portfolio of healthcare companies and has established itself as a key player in the healthcare investment landscape since its inception.
Frist Cressey Ventures exclusively invests in healthcare-related companies that aim to innovate and improve patient care. Their investment strategy encompasses various sectors within healthcare, including behavioral health, oncology, digital health, palliative care, and administrative burden reduction. The firm targets investments in companies that utilize technology to enhance patient outcomes and address systemic challenges in the healthcare system.
FCV typically invests in companies at the seed through Series B stages, with check sizes ranging from $1 million to $60 million. The firm seeks to partner with founders who are committed to transforming healthcare delivery and improving patient experiences.
Frist Cressey Ventures has built a diverse portfolio of notable healthcare companies, including:
Senator Bill Frist, M.D. - Co-Founder & Managing Partner; former U.S. Senate Majority Leader and cardiothoracic surgeon; Harvard Medical School graduate.
Bryan Cressey - Co-Founder & Senior Advisor; a pioneer in private equity investing with over 30 years of experience in healthcare; Harvard Law School and Harvard Business School graduate.
Navid Farzad - Managing Partner; previously with Morgan Noble Healthcare Partners and Enhanced Healthcare Partners.
Olivia Capra - Partner; former Kaiser Permanente Ventures and Convey Capital; holds a CFA designation.
J. Mark Tipps - Partner & COO; former chief of staff to Senator Frist; holds a J.D. from UT Law.
To pitch Frist Cressey Ventures, founders should use the contact form available on their website at fcventures.com. It is important to include a comprehensive deck that outlines the business model, market opportunity, and how the startup plans to address healthcare challenges. Response times may vary, but founders are encouraged to provide a clear and concise presentation of their vision.
Frist Cressey Ventures runs several initiatives aimed at fostering collaboration and innovation in healthcare, including:
In February 2026, Frist Cressey Ventures closed its Fund IV at $425 million, which was oversubscribed. The firm continues to expand its portfolio with significant investments in healthcare companies focused on improving patient outcomes.
Q? What are the investment criteria for Frist Cressey Ventures?
A Frist Cressey Ventures invests exclusively in healthcare-related companies that innovate and improve patient care, focusing on sectors such as behavioral health, digital health, and palliative care.
Q? How can founders pitch to Frist Cressey Ventures?
A Founders can pitch through the firm's website at fcventures.com. It is advisable to include a clear outline of the business model, market opportunity, and how the company addresses healthcare challenges.
Q? What is the typical check size for investments?
A Frist Cressey Ventures typically invests between $1 million and $60 million in its portfolio companies.
Q? What stages does Frist Cressey Ventures invest in?
A The firm invests in companies at the seed through Series B stages.
Q? How involved is Frist Cressey Ventures post-investment?
A The firm adds value through strategic partnerships, access to a network of healthcare leaders, and insights into regulatory and policy issues affecting the healthcare landscape.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.